Knowledge Base

How many sequence modifications exist in the protein sequence?

19 December 2023
2 min read

It is hard to determine how many types of protein sequence modifications exist due to post-translational modifications (PTMs), a natural process where additional components are added or removed from the protein sequence after it is initially generated. These modifications, which can alter the function, cellular localization, and lifespan of proteins, include:

1. Phosphorylation: The addition of a phosphate group, usually to serine, threonine, or tyrosine residues.

2. Acetylation: One of the most common modifications, typically occurring at the N-terminus of the protein or at lysine residues.

3. Ubiquitination: A stepwise process involving the attachment of ubiquitin, a small regulatory protein, to lysine residues. Ubiquitination often marks proteins for degradation.

4. Methylation: Addition of a methyl group, commonly to lysine or arginine residues, leading to structural changes in proteins.

5. Glycosylation: Covalent attachment of sugar molecules, resulting in O-linked (usually attached to serine or threonine) or N-linked (attached to asparagine) glycosylation.

6. Sumoylation: Similar to ubiquitination, a small ubiquitin-like modifier (SUMO) protein is attached to certain lysine residues.

7. Sulfation: Addition of a sulfate group, frequently on tyrosine residues.

8. Prenylation: The addition of prenyl groups to certain cysteine residues, often involved in membrane-targeting.

9. Carboxylation: The addition of a carboxyl group, often to glutamate residues.

10. Nitrosylation: The addition of a nitrosyl group, typically to cysteine residues.

The exact number of protein modifications is difficult to estimate due to the complexity and variability of these processes, but there are at least 200 types of known PTMs. The specific proteins and residues they modify, their timing, and their functional effects can all vary.

NAYA Biosciences publishes new insights on CD38-targeting Flex-NK™ dual-specific antibody in American Society of Hematology journal
Latest Hotspot
3 min read
NAYA Biosciences publishes new insights on CD38-targeting Flex-NK™ dual-specific antibody in American Society of Hematology journal
19 December 2023
NAYA Biosciences Reveals New Findings on Its CD38-Directed Flex-NK™ Dual-Specific Antibody in the Journal Published by the American Society of Hematology.
Read →
Understanding Ras Inhibitors and Methods to Keep Abreast of Their Recent Developments
Understanding Ras Inhibitors and Methods to Keep Abreast of Their Recent Developments
19 December 2023
Ras inhibitors are drugs that target Ras proteins, crucial in cell signaling pathways. The future sees potential applications in treating various cancers.
Read →
IASO Bio and Innovent released new data on Equecabtagene Autoleucel (FUCASO®) for multiple myeloma at ASH 2023
Latest Hotspot
3 min read
IASO Bio and Innovent released new data on Equecabtagene Autoleucel (FUCASO®) for multiple myeloma at ASH 2023
19 December 2023
IASO Bio alongside Innovent unveiled fresh Equecabtagene Autoleucel (FUCASO®) findings for those affected by multiple myeloma, during the 2023 ASH conference.
Read →
What are adverse drug reactions?
"What" Series
2 min read
What are adverse drug reactions?
19 December 2023
Adverse drug reaction (ADR) refers to the harmful reactions of qualified drugs that are unrelated to the purpose of medication under normal usage and dosage.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.